157 related articles for article (PubMed ID: 20067337)
1. Predictive performance of the 'Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass.
La Colla L; Albertin A; La Colla G; Porta A; Aldegheri G; Di Candia D; Gigli F
Clin Pharmacokinet; 2010; 49(2):131-9. PubMed ID: 20067337
[TBL] [Abstract][Full Text] [Related]
2. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia.
Mertens MJ; Engbers FH; Burm AG; Vuyk J
Br J Anaesth; 2003 Feb; 90(2):132-41. PubMed ID: 12538367
[TBL] [Abstract][Full Text] [Related]
3. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
4. Predictive performance of 'Servin's formula' during BIS-guided propofol-remifentanil target-controlled infusion in morbidly obese patients.
Albertin A; Poli D; La Colla L; Gonfalini M; Turi S; Pasculli N; La Colla G; Bergonzi PC; Dedola E; Fermo I
Br J Anaesth; 2007 Jan; 98(1):66-75. PubMed ID: 17132644
[TBL] [Abstract][Full Text] [Related]
5. Performance of alfentanil target-controlled infusion in normal and morbidly obese female patients.
Pérus O; Marsot A; Ramain E; Dahman M; Paci A; Raucoules-Aimé M; Simon N
Br J Anaesth; 2012 Oct; 109(4):551-60. PubMed ID: 22732112
[TBL] [Abstract][Full Text] [Related]
6. Performance of target-controlled sufentanil infusion in obese patients.
Slepchenko G; Simon N; Goubaux B; Levron JC; Le Moing JP; Raucoules-Aimé M
Anesthesiology; 2003 Jan; 98(1):65-73. PubMed ID: 12502981
[TBL] [Abstract][Full Text] [Related]
7. Remifentanil pharmacokinetics in obese versus lean patients.
Egan TD; Huizinga B; Gupta SK; Jaarsma RL; Sperry RJ; Yee JB; Muir KT
Anesthesiology; 1998 Sep; 89(3):562-73. PubMed ID: 9743391
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic model-driven remifentanil administration in the morbidly obese: the 'critical weight' and the 'fictitious height', a possible solution to an unsolved problem?
La Colla L; Albertin A; La Colla G
Clin Pharmacokinet; 2009; 48(6):397-8. PubMed ID: 19650678
[No Abstract] [Full Text] [Related]
9. Reliability of the Minto model for target-controlled infusion of remifentanil during cardiac surgery with cardiopulmonary bypass.
Scherrer V; Lamoureux F; Chaventre C; Thill C; Demailly Z; Selim J; Bauer F; Imbert L; Wurtz V; Compère V; Clavier T; Besnier E
Br J Anaesth; 2022 Aug; 129(2):163-171. PubMed ID: 35750514
[TBL] [Abstract][Full Text] [Related]
10. Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.
Coetzee JF
Clin Pharmacokinet; 2012 Mar; 51(3):137-45. PubMed ID: 22316280
[TBL] [Abstract][Full Text] [Related]
11. Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement.
De Castro V; Godet G; Mencia G; Raux M; Coriat P
Anesth Analg; 2003 Jan; 96(1):33-8, table of contents. PubMed ID: 12505919
[TBL] [Abstract][Full Text] [Related]
12. External Validation of a Recently Developed Population Pharmacokinetic Model for Hydromorphone During Postoperative Pain Therapy.
Ihmsen H; Rohde D; Schüttler J; Jeleazcov C
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):17-28. PubMed ID: 26797808
[TBL] [Abstract][Full Text] [Related]
13. Closed-loop control of propofol anaesthesia using bispectral index: performance assessment in patients receiving computer-controlled propofol and manually controlled remifentanil infusions for minor surgery.
Absalom AR; Kenny GN
Br J Anaesth; 2003 Jun; 90(6):737-41. PubMed ID: 12765888
[TBL] [Abstract][Full Text] [Related]
14. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
[TBL] [Abstract][Full Text] [Related]
15. Performance of the Minto model for the target-controlled infusion of remifentanil during cardiopulmonary bypass.
Cho YJ; Jo WY; Oh H; Koo CH; Oh J; Cho JY; Yu KS; Jeon Y; Kim TK
Anaesthesia; 2017 Oct; 72(10):1196-1205. PubMed ID: 28891056
[TBL] [Abstract][Full Text] [Related]
16. No correlation between remifentanil blood, cerebrospinal fluid and cerebral extracellular fluid levels and TCI prediction: a pharmacokinetic study.
Piacevoli Q; Del Gaudio A; Mincolelli G; Tonti MP; Wouters G; Mastronardi P
Minerva Anestesiol; 2015 Mar; 81(3):305-11. PubMed ID: 25057929
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of target controlled infusion system for sufentanil administration.
Zhao Y; Zhang LP; Wu XM; Jiang JY; Duan JL; Hu YF; Li M; Liu W; Sheng XY; Ni C; Xu M; Guo XY
Chin Med J (Engl); 2009 Oct; 122(20):2503-8. PubMed ID: 20079167
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of anesthesia in morbidly obese patients using propofol with continuous BIS-monitoring: a comparison of propofol-remifentanil and propofol-epidural anesthesia.
van Kralingen S; van de Garde EM; van Dongen EP; Diepstraten J; Deneer VH; van Ramshorst B; Knibbe CA
Acta Anaesthesiol Belg; 2011; 62(2):73-82. PubMed ID: 21919373
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.
Egan TD; Lemmens HJ; Fiset P; Hermann DJ; Muir KT; Stanski DR; Shafer SL
Anesthesiology; 1993 Nov; 79(5):881-92. PubMed ID: 7902032
[TBL] [Abstract][Full Text] [Related]
20. Influence of Remifentanil on the Control Performance of the Bispectral Index Controlled Bayesian-Based Closed-Loop System for Propofol Administration.
Neckebroek M; Boldingh JHL; De Smet T; Struys MMRF
Anesth Analg; 2020 Jun; 130(6):1661-1669. PubMed ID: 31107260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
